DE ROSA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 2.628
EU - Europa 1.819
AS - Asia 1.294
SA - Sud America 204
OC - Oceania 36
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.018
Nazione #
US - Stati Uniti d'America 2.588
IT - Italia 794
CN - Cina 437
SG - Singapore 394
GB - Regno Unito 367
HK - Hong Kong 166
BR - Brasile 165
SE - Svezia 133
DE - Germania 126
FI - Finlandia 89
RU - Federazione Russa 84
VN - Vietnam 80
ID - Indonesia 43
KR - Corea 37
NL - Olanda 31
UA - Ucraina 31
TR - Turchia 30
IN - India 28
NZ - Nuova Zelanda 24
FR - Francia 23
JP - Giappone 20
ZA - Sudafrica 19
CA - Canada 18
AR - Argentina 16
BG - Bulgaria 16
PL - Polonia 16
CZ - Repubblica Ceca 15
AT - Austria 14
MX - Messico 14
SI - Slovenia 14
AU - Australia 12
BE - Belgio 12
IR - Iran 11
LT - Lituania 11
BD - Bangladesh 9
ES - Italia 9
DK - Danimarca 8
EC - Ecuador 8
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
IL - Israele 5
CL - Cile 4
EG - Egitto 4
MA - Marocco 4
UZ - Uzbekistan 4
IE - Irlanda 3
IQ - Iraq 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
RO - Romania 3
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BF - Burkina Faso 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
IS - Islanda 1
JO - Giordania 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
PH - Filippine 1
SV - El Salvador 1
UY - Uruguay 1
Totale 6.018
Città #
Santa Clara 334
Ashburn 298
Fairfield 245
Singapore 239
Southend 222
Hong Kong 162
Hefei 158
Woodbridge 158
Chandler 141
Houston 131
Ann Arbor 107
Cambridge 100
Seattle 98
Beijing 82
Modena 78
London 75
Wilmington 75
Bari 72
Bologna 72
Nyköping 67
Helsinki 63
Dearborn 59
Jacksonville 57
Milan 46
Rome 46
Los Angeles 45
Jakarta 38
Munich 38
New York 38
Seoul 36
Ho Chi Minh City 27
Medesano 27
Chicago 25
San Diego 24
Auckland 22
Council Bluffs 22
Moscow 20
São Paulo 19
The Dalles 19
Formigine 18
Buffalo 17
Princeton 17
Salt Lake City 17
Shanghai 17
Hanoi 16
Sofia 16
Turku 14
Dallas 13
Reggio Emilia 13
Bremen 12
Brussels 12
Frankfurt am Main 12
Warsaw 12
Eugene 11
Goito 11
Izmir 11
Redondo Beach 11
Stockholm 11
Turin 11
Brno 10
Brooklyn 10
Falls Church 10
Kent 10
Tokyo 10
Noceto 9
Redwood City 9
San Jose 9
Vienna 9
Dong Ket 8
Fremont 8
Parma 8
Phoenix 8
Columbus 7
Montreal 7
Naples 7
Napoli 7
Rio de Janeiro 7
Boardman 6
Brasília 6
Carpi 6
Hatfield 6
Melbourne 6
Novellara 6
Nuremberg 6
Rimini 6
Tampa 6
Utrecht 6
Washington 6
Elk Grove Village 5
Manchester 5
Porto Alegre 5
Pretoria 5
San Lazzaro di Savena 5
Sterling 5
Terni 5
Trieste 5
Barcelona 4
Cedar Knolls 4
Changsha 4
Chennai 4
Totale 4.132
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 633
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 527
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 339
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 332
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 316
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 310
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 305
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 280
The long and winding road that leads to a cure for epidermolysis bullosa 264
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 237
Cell biology: Dormant and restless skin stem cells 220
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 216
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 209
Advances on potential therapeutic options for epidermolysis bullosa 194
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 184
Stairways to Advanced Therapies for Epidermolysis Bullosa 182
Toward combined cell and gene therapy for genodermatoses 156
AlPaCas: allele-specific CRISPR gene editing through a protospacer-adjacent-motif (PAM) approach 146
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa 130
Epigenetic and metabolic regulation of epidermal homeostasis 126
Transgenic epidermal cultures for junctional epidermolysis bullosa — 5-year outcomes 124
Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome 117
p63 Suppresses non-epidermal lineage markers in a bone morphogenetic protein-dependent manner via repression of Smad7 115
The joint battle to tackle epidermolysis bullosa through gene therapy 113
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome 103
TAp63 is important for cardiac differentiation of embryonic stem cells and heart development 89
Tprg, a Gene Predominantly Expressed in Skin, Is a Direct Target of the Transcription Factor p63 81
Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells 60
Totale 6.108
Categoria #
all - tutte 23.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.771


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 0 48 59 36 146 67 21
2021/2022503 24 20 57 24 30 52 37 44 58 31 79 47
2022/2023545 68 61 42 51 51 57 28 53 79 12 24 19
2023/2024567 13 17 34 47 55 56 41 83 24 92 28 77
2024/20251.552 58 30 56 97 254 227 132 94 145 56 204 199
2025/20261.373 212 130 214 266 355 187 9 0 0 0 0 0
Totale 6.108